Breakout Stocks
BWAY is part of our breakout stocks list, indicating it is showing strong recent technical strength.
BRAINSWAY LTD-ADR (BWAY) Stock Price & Overview
NASDAQ:BWAY • US10501L1061
Current stock price
16.69 USD
+0.13 (+0.79%)
Last:
The current stock price of BWAY is 16.69 USD. Today BWAY is up by 0.79%. In the past month the price increased by 21.94%. In the past year, price increased by 634.37%.
BWAY Key Statistics
52-Week Range2.15125 - 16.69
Current BWAY stock price positioned within its 52-week range.
1-Month Range12.04 - 16.69
Current BWAY stock price positioned within its 1-month range.
- Market Cap
- 668.151M
- P/E
- 26.49
- Fwd P/E
- 21.13
- EPS (TTM)
- 0.63
- Dividend Yield
- N/A
BWAY Stock Performance
Today
+0.79%
1 Week
+5.14%
1 Month
+21.94%
3 Months
+183.32%
Longer-term
6 Months +293.12%
1 Year +634.37%
2 Years +1,161.71%
3 Years +4,173.55%
5 Years +668.45%
10 Years N/A
BWAY Stock Chart
BWAY Stock Screens
BWAY currently appears in the following ChartMill screener lists.
BWAY Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to BWAY. When comparing the yearly performance of all stocks, BWAY is one of the better performing stocks in the market, outperforming 99.46% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
BWAY Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BWAY. BWAY has an excellent financial health rating, but there are some minor concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
BWAY Earnings
On March 11, 2026 BWAY reported an EPS of 0.25 and a revenue of 47.19M. The company beat EPS expectations (97.97% surprise) and beat revenue expectations (2.3% surprise).
Next Earnings DateMay 13, 2026
Last Earnings DateMar 11, 2026
PeriodQ4 / 2025
EPS Reported$0.25
Revenue Reported47.19M
EPS Surprise 97.97%
Revenue Surprise 2.30%
BWAY Forecast & Estimates
7 analysts have analysed BWAY and the average price target is 0.05 USD. This implies a price decrease of -99.68% is expected in the next year compared to the current price of 16.69.
For the next year, analysts expect an EPS growth of 25.19% and a revenue growth 25.98% for BWAY
Analysts
Analysts85.71
Price Target0.05 (-99.7%)
EPS Next Y25.19%
Revenue Next Year25.98%
BWAY Financial Highlights
Over the last trailing twelve months BWAY reported a non-GAAP Earnings per Share(EPS) of 0.63. The EPS increased by 117.91% compared to the year before.
Income Statements
Revenue(TTM)N/A
Net Income(TTM)6.25M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.73% | ||
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| Debt/Equity | 0.08 |
Chartmill High Growth Momentum
EPS Q2Q%75.68%
Sales Q2Q%11.8%
EPS 1Y (TTM)117.91%
Revenue 1Y (TTM)N/A
BWAY Ownership
Ownership
Inst Owners5.26%
Shares40.03M
Float33.96M
Ins Owners15.17%
Short Float %0.3%
Short Ratio0.66
BWAY Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 39.44 | 162.529B | ||
| ABT | ABBOTT LABORATORIES | 14.31 | 157.763B | ||
| SYK | STRYKER CORP | 17.8 | 120.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.56 | 85.619B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.94 | 48.141B | ||
| IDXX | IDEXX LABORATORIES INC | 38.46 | 44.539B | ||
| BDX | BECTON DICKINSON AND CO | 10.94 | 42.438B | ||
| RMD | RESMED INC | 16.48 | 31.148B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 10.7 | 27.761B | ||
| DXCM | DEXCOM INC | 20.15 | 22.918B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.11 | 15.956B | ||
| PEN | PENUMBRA INC | 64.05 | 12.837B | ||
| GMED | GLOBUS MEDICAL INC - A | 19.99 | 12.197B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BWAY
Company Profile
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Company Info
IPO: 2006-12-24
BRAINSWAY LTD-ADR
16 Hartum Street Rad Tower, 14Th Floor, Har HaHotzvim
JERUSALEM 9777518 IL
CEO: Christopher R. von Jako
Employees: 120
Phone: 97225813140
BRAINSWAY LTD-ADR / BWAY FAQ
What does BWAY do?
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Can you provide the latest stock price for BRAINSWAY LTD-ADR?
The current stock price of BWAY is 16.69 USD. The price increased by 0.79% in the last trading session.
What is the dividend status of BRAINSWAY LTD-ADR?
BWAY does not pay a dividend.
How is the ChartMill rating for BRAINSWAY LTD-ADR?
BWAY has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the employee count for BWAY stock?
BRAINSWAY LTD-ADR (BWAY) currently has 120 employees.
What is the market capitalization of BWAY stock?
BRAINSWAY LTD-ADR (BWAY) has a market capitalization of 668.15M USD. This makes BWAY a Small Cap stock.
When does BRAINSWAY LTD-ADR (BWAY) report earnings?
BRAINSWAY LTD-ADR (BWAY) will report earnings on 2026-05-13.